Jefferies Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Jefferies Group’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-16,930	Closed	-$35K	–	2674
2014 Q3	$35K	Buy	+16,930	New	+$35K	﹤0.01%	2008
2013 Q4	–	Sell	-31,626	Closed	-$72K	–	2499
2013 Q3	$72K	Buy	+31,626	New	+$72K	﹤0.01%	1745

Jefferies Group's RXII Position: Q4 2014 in Review

Jefferies Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2014, closing a stake of 16,930 shares — an estimated $35K sold.

Jefferies Group first reported a position in RXII in Q3 2013 and held it in 2 quarters. The position peaked at $72K in Q3 2013. 79 funds tracked by Wall St. Rank hold RXII as of Q4 2014.

Jefferies Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2014 after selling out during the quarter.
Jefferies Group sold 16,930 GALENA BIOPHARMA INC COM shares in Q4 2014, an estimated $35K.
Jefferies Group first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 2 quarters.
Jefferies Group's GALENA BIOPHARMA INC COM position peaked at $72K in Q3 2013.
79 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2014.

Based on Jefferies Group's 13F filing for Q4 2014, filed 17 Feb 2015.